We know many families were hoping for encouraging news from the recent Phase 3 trial of eDSP. Sadly, Quince Therapeutics has announced that the treatment did not show the improvement researchers were looking for, and as a result, they will be stopping further development of this therapy.
Please click below to read Quince’s full statement.











